Skin cancer and HLA antigens

Comment

P L Myskowski. N Engl J Med. 1992.

. 1992 Mar 12;326(11):765; author reply 766.

doi: 10.1056/NEJM199203123261111.

No abstract available

Comment on

Relation between skin cancer and HLA antigens in renal-transplant recipients.
Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GM, Thorogood J, Persijn GG, Claas FH. Bouwes Bavinck JN, et al. N Engl J Med. 1991 Sep 19;325(12):843-8. doi: 10.1056/NEJM199109193251203. N Engl J Med. 1991. PMID: 1875968

Multiple basal cell carcinoma in tropical Australia.
Czarnecki D, Collins N, Chow P, Nicholson I, Tait B. Czarnecki D, et al. Int J Dermatol. 1992 Sep;31(9):635-6. doi: 10.1111/j.1365-4362.1992.tb03982.x. Int J Dermatol. 1992. PMID: 1459761
HLA-DR1 is not a sign of poor prognosis for the development of multiple basal cell carcinomas.
Czarnecki D, Lewis A, Nicholson I, Tait B, Nash C. Czarnecki D, et al. J Am Acad Dermatol. 1992 May;26(5 Pt 1):717-9. doi: 10.1016/0190-9622(92)70099-2. J Am Acad Dermatol. 1992. PMID: 1583170
HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
Glover MT, Bodmer J, Bodmer W, Kennedy LJ, Brown J, Navarrete C, Kwan JT, Leigh IM. Glover MT, et al. Eur J Cancer. 1993;29A(4):520-4. doi: 10.1016/s0959-8049(05)80143-1. Eur J Cancer. 1993. PMID: 8435203
HLA and skin cancer.
Bonamigo RR, Carvalho AV, Sebastiani VR, Silva CM, Pinto AC. Bonamigo RR, et al. An Bras Dermatol. 2012 Jan-Feb;87(1):9-16; quiz 17-8. doi: 10.1590/s0365-05962012000100001. An Bras Dermatol. 2012. PMID: 22481646 Review.
Immune response to basal cell and squamous cell carcinomas.
Grimwood RE. Grimwood RE. Immunol Ser. 1989;46:789-98. Immunol Ser. 1989. PMID: 2488879 Review.